Raymond James & Associates’s Establishment Labs ESTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,546
Closed -$207K 4027
2024
Q2
$207K Buy
+4,546
New +$231K ﹤0.01% 3585
2023
Q4
Sell
-4,250
Closed -$209K 3861
2023
Q3
$209K Hold
4,250
﹤0.01% 3427
2023
Q2
$292K Hold
4,250
﹤0.01% 3275
2023
Q1
$288K Hold
4,250
﹤0.01% 3264
2022
Q4
$279K Sell
4,250
-93
-2% -$5.62K ﹤0.01% 3262
2022
Q3
$237K Hold
4,343
﹤0.01% 3332
2022
Q2
$236K Hold
4,343
﹤0.01% 3392
2022
Q1
$293K Buy
4,343
+93
+2% +$5.44K ﹤0.01% 3430
2021
Q4
$287K Sell
4,250
-24
-0.6% -$1.68K ﹤0.01% 3464
2021
Q3
$306K Buy
4,274
+24
+0.6% +$1.77K ﹤0.01% 3397
2021
Q2
$371K Hold
4,250
﹤0.01% 3288
2021
Q1
$266K Buy
+4,250
New +$245K ﹤0.01% 3434

Other funds holding ESTA

Raymond James & Associates's ESTA Position: Q3 2024 in Review

Raymond James & Associates sold out of Establishment Labs (ESTA) in Q3 2024, closing a stake of 4,546 shares — an estimated $207K sold.

Raymond James & Associates first reported a position in ESTA in Q1 2021 and held it in 12 quarters. The position peaked at $371K in Q2 2021. 130 funds tracked by Wall St. Rank hold ESTA as of Q3 2024.

  • Raymond James & Associates reported no remaining Establishment Labs position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 4,546 Establishment Labs shares in Q3 2024, an estimated $207K.
  • Raymond James & Associates first reported a position in Establishment Labs in Q1 2021 and held it in 12 quarters.
  • Raymond James & Associates's Establishment Labs position peaked at $371K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Establishment Labs as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.